These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. Fidler IJ; Gruys E; Cifone MA; Barnes Z; Bucana C J Natl Cancer Inst; 1981 Oct; 67(4):947-56. PubMed ID: 6944560 [TBL] [Abstract][Full Text] [Related]
23. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. Kozlowski JM; Hart IR; Fidler IJ; Hanna N J Natl Cancer Inst; 1984 Apr; 72(4):913-7. PubMed ID: 6584666 [TBL] [Abstract][Full Text] [Related]
24. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras. Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141 [TBL] [Abstract][Full Text] [Related]
25. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Wang BS; McLoughlin GA; Richie JP; Mannick JA Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511 [TBL] [Abstract][Full Text] [Related]
26. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Fidler IJ; Talmadge JE Cancer Res; 1986 Oct; 46(10):5167-71. PubMed ID: 3756870 [TBL] [Abstract][Full Text] [Related]
27. Intrapulmonary spread of established B16 melanoma lung metastases and lung colonies. Stackpole CW Invasion Metastasis; 1990; 10(5):267-80. PubMed ID: 2228515 [TBL] [Abstract][Full Text] [Related]
28. Metastatic heterogeneity of cells from Lewis lung carcinoma. van Lamsweerde AL; Henry N; Vaes G Cancer Res; 1983 Nov; 43(11):5314-20. PubMed ID: 6616467 [TBL] [Abstract][Full Text] [Related]
29. Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma. Saha S; Mohanty KC J Exp Clin Cancer Res; 2003 Mar; 22(1):125-34. PubMed ID: 12725332 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861 [TBL] [Abstract][Full Text] [Related]
31. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis. Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230 [TBL] [Abstract][Full Text] [Related]
32. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells. Trainer DL; Kline T; Mallon F; Greig R; Poste G Cancer Res; 1985 Dec; 45(12 Pt 1):6124-30. PubMed ID: 2415238 [TBL] [Abstract][Full Text] [Related]
33. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Fidler IJ; Gersten DM; Budmen MB Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082 [TBL] [Abstract][Full Text] [Related]
34. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials. LeGrue SJ; Hearn DR Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449 [TBL] [Abstract][Full Text] [Related]
35. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075 [TBL] [Abstract][Full Text] [Related]
36. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606 [TBL] [Abstract][Full Text] [Related]
37. Growth rate and chromosome number of tumor cell lines with different metastatic potential. Cifone MA; Kripke ML; Fidler IJ J Supramol Struct; 1979; 11(4):467-76. PubMed ID: 544925 [TBL] [Abstract][Full Text] [Related]
38. Melanoma cells selected for adhesion to laminin peptides have different malignant properties. Yamamura K; Kibbey MC; Kleinman HK Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834 [TBL] [Abstract][Full Text] [Related]
39. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma. Parratto NP; Odebralski JM; Kimura AK Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512 [TBL] [Abstract][Full Text] [Related]